History and development of Eye Acupuncture

Prof. John Boel practices eye acupuncture on patient (Prof. John Boel)

Prof. John Boel practices eye acupuncture on patient (Prof. John Boel)

In the 90’s, a new treatment system, eye acupuncture was born. The new science was named Acupuncture 2000, but since many confused it with Chinese acupuncture, Acupuncture 2000 was changed to AcuNova, which means “New Acupuncture”.

Discovery of Eye Acupuncture

Danish acupuncturist John Boel discovered that there are points in and around all joints that are extremely effective in treating pain, organic diseases and so-called incurable eye diseases, such as dry macular degeneration – even in cases where medical science has advised, “You must learn to live with it.”

Prof. John Boel, as well as a handful of scientists spent a lot of time researching the new system. They compiled points from different acupuncture systems into a therapeutic concept. As the research progressed, they realized that AcuNova contained unique potentials not seen before in the known healthcare system.

Dissemination of acupuncture

A lot has happened since the spread of this new treatment method. 4,000 alternative practitioners, doctors and other medical professionals from about 50 countries have learned AcuNova, eye acupuncture.

Talks about AcuNova were held at international conferences in China, Germany, Switzerland, Austria, Spain, Norway and Sri Lanka – where scientists from over 100 countries came together to learn together. Participants were very enthusiastic about AcuNova and John Boel was the first in the world to be honored with the title “Acupuncturist of the Century” for his discovery.

More than 250,000 patients are now treated with the acupuncture system every week worldwide.

Research results of Eye Acupuncture

Trials were conducted with AcuNova for the treatment of age-related macular degeneration (AMD). 40 patients were treated during the day at Prof. Boel’s clinic.

The AMD patients were divided into three groups.

Among other things, Boel also tested whether two weeks of intensive treatment were better than the previously used one week. Therefore, the subjects received two treatments a day for a period of two weeks (except on weekends), and then continuous treatments, that is, one treatment every 2 to 4 weeks. In total, the patients received 30 acupuncture sessions.

The 3 groups were treated with different ocular acupuncture systems. (AcuNova 1, AcuNova 2 and AcuNova 3).

During treatment, visual performance was examined periodically with the eye chart. After 4 weeks, the results were evaluated for 6 months.

Research results with different eye acupuncture systems (Noll)

Research results with different eye acupuncture systems (Noll)

The AcuNova 3 group achieved an optical improvement between 15-40%. The average improvement in visual acuity was 27%. Of the three methods used on the patients, two acupuncture systems gave worse results. Therefore, the method used in the best group (AcuNova 3) was immediately introduced as a basic treatment for all eye patients.

According to the experience, the results can be transferred to patients with other eye diseases.

This result was confirmed by daily treatment in Boel acupuncture clinics in Aulum and Copenhagen. Over the past five years, the clinics treated 4,985 AMD patients. 83% of the 4,985 AMD patients achieved visual improvement of at least 15%.

During the first two weeks, AMD patients received 20 treatments (two treatments per weekday), and two treatments per month thereafter to maintain visual improvement.

Prof. John Boel practices eye acupuncture in China (Prof. John Boel)

Prof. John Boel practices eye acupuncture in China (Prof. John Boel)

When AcuNova was introduced in 1999, researchers still did not know how long the improvement would last. In cases where a slight decline was observed after a few years, the patients were treated intensively for one week, and thus vision was improved again in most cases.

Eye Acupuncture research

In Germany, a Boel student, Hans Peter Wutta, MD, has conducted scientific research on eye acupuncture, and has published a book about it with Ehrenwirth-Verlag: ISBN 3-431-04030-6.

Dr. Hans Peter Wutta from Kiel is an acupuncture physician. In recent years he has been intensively involved in the treatment of eye diseases with AcuNova (eye acupuncture). He has also conducted research on the effects of eye acupuncture.

The treatment was performed with Boel’s eye acupuncture.

Patients were examined before and after treatment, and then statistically treated by the University of Hamburg. The results of this test and longer stagnation of the disease were the criteria used.

The results in both men and women were surprisingly good, with 76% benefiting from the treatments.

Dr. Wutta also tested whether the age of the patients affected the results and he concluded that the results were the same no matter how young or old the patient was.

Effect of Eye Acupuncture

Through a point, a signal can be transmitted through the nervous system to the brain. This then starts the same process that the body usually uses to heal disease. What is new is that this self-healing process can be started with AcuNova.

AcuNova is a new science. It was not developed in the laboratory, but through practical experience. Boel does not see himself as a scientist, but as a craftsman.

Since 1995, special training courses for Boel’s eye acupuncture method have been offered in German-speaking countries. In cooperation with many doctors and alternative practitioners who successfully use this method, I have greatly expanded Boel’s basic acupuncture to further optimize the therapy. In addition, I support the patient with supplementary therapy measures such as UV-B treatment, phytotherapy, infusions, bioresonance therapy / light therapy which again significantly improve the course of recovery.

If you are affected yourself and suffer from macular degeneration (AMD, Age-related macular degeneration) or glaucoma, I will be happy to advise you on the treatment options with eye acupuncture according to Prof. John Boel.

Durch die weitere Nutzung der Seite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close